Coronavirus / COVID

A placebo-controlled trial of hydroxychloroquine in patients hospitalized with COVID-19 finds the drug shortened time to recovery, possibly lessened severity.

By giving patients plasma or serum from patients who have developed antibodies to a particular virus or bacteria, an infected patient is given a massive boost to their adaptive immune system, which confers passive immunity.

Check out the latest coronavirus news from April 3, 2020.

As communities around the world race to treat patients with COVID-19, a new problem is emerging: how to deal with the rise in fatalities.

The coronavirus pandemic is disrupting clinical trials for multiple diseases, from Alzheimer's to Zika.

Check out the latest coronavirus news from April 2, 2020.

There are now over 1 million cases confirmed in the global COVID-19 pandemic.

A report from the CDC’s COVID-19 Response Team includes preliminary data on patients with the highest risk of severe infection.

The authors of the analysis broke down palliative care during a pandemic into 8 critical categories.

In mouse models, the vaccine produced antibodies for SARS-CoV-2 which may offer sufficient protection.

Christina Tan, MD, MPH, from the New Jersey Department of Health discusses COVID-19.

Listen for a daily COVID-19 update.

Investigators recommend extending quarantine periods for recovering COVID-19 patients by an additional 2 weeks.

The virtual MJH Life Sciences Sleeves Up Blood Drive is being held from March 31 through April 30.

In a new editorial a team of engineers and computer scientists argue that the current pandemic moment ought to serve as a wake-up call for society and the public health community to embrace the opportunities of robotics.

A new commentary argues that the gradual pace at which we research other health challenges is not appropriate for a global pandemic.

Investigators look to answer questions about breast milk’s protective effects for infants from COVID-19, the infection caused by the novel coronavirus.

COVID-19 does not present our first pandemic, nor will it be our last. What should we take note of?

The goal of the program will be to quickly bring effective medical countermeasures to patients while also supporting research to assess the safety and efficacy of these therapies.

Listen for a daily COVID-19 update.

As March comes to an end, we look back at an unprecedented month in infectious disease news.

New guidelines on COVID-19 from WHO, CDC, and CMS advise long-term care facilities on protecting their elderly, vulnerable populations and staff.

Babies at risk for coronavirus due to maternal COVID-19 pneumonia showed favorable outcomes.

Stay up to date with our daily COVID-19 update.

As of March 30th, 20 emergency use authorizations have been granted for COVID-19 diagnostics.